Investigation of Gait Characteristics in Pediatric ALL Patients

Overview of Acute Lymphoblastic Leukemia

Childhood acute lymphoblastic leukemia (ALL) is marked by the excessive production of immature lymphocytes, which are ineffective in combating infections. Recent advancements in chemotherapy have improved survival rates to nearly 90%. However, these treatments often lead to both short-term and long-term adverse effects that can significantly impact a patient’s quality of life.

Chemotherapy-Induced Peripheral Neuropathy

Vincristine is a widely used chemotherapeutic agent for treating ALL, but it is associated with various peripheral neuropathies. These include distal weakness, numbness, tingling, cramping, pain, muscle contractures, skeletal deformities, and atypical gait patterns.

Study on Gait Characteristics

A recent study published in *Gait & Posture* examined the gait characteristics of pediatric patients with chemotherapy-induced peripheral neuropathy (CIPN). The research involved 17 patients aged five years and older diagnosed with CIPN and 10 typically developing children who served as a control group. The researchers employed three-dimensional motion analysis (3-DMA) to assess gait characteristics and the extent of deviation from typical patterns. Additionally, simultaneous electromyography (EMG) was utilized to evaluate muscle function during walking and other physical activities.

Findings of the Study

The study revealed that patients with CIPN exhibited notable deviations across EMG, kinematic, kinetic, and temporal spatial patterns throughout their gait cycles. Furthermore, there was significant variability in gait pattern deviations among the CIPN patients, likely due to factors such as asymmetrical neuropathy, other impairments, variations in activity during treatment, age, and duration of therapy. These deviations are attributed to both the neuropathy itself and compensatory mechanisms that patients develop to alleviate pain and enhance stability. Notably, the study indicated that these gait pattern deviations persist even after treatment has concluded, highlighting potential long-term implications for pediatric patients undergoing chemotherapy.

Implications for Treatment

The findings indicate substantial differences in gait patterns between patients with and without CIPN, as well as considerable variability among those with CIPN. This underscores the necessity for personalized treatment approaches rather than generalized strategies. Future research could benefit from larger sample sizes to further substantiate these findings and possibly inform new prevention and treatment strategies for pediatric cancer patients suffering from chemotherapy-induced peripheral neuropathy.

Author Information

Written by Haisam Shah, BSc.

Reference

Wright, M. J., Twose, D. M., & Gorter, J. W. (2017). Gait Characteristics of Children and Youth With Chemotherapy Induced Peripheral Neuropathy Following Treatment for Acute Lymphoblastic Leukemia. *Gait & Posture*.